Intraday BUY SELL Signals
59 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement
Advertisement
EFAV vs GSK
EFAV vs GSK Comparison
Open Charts EFAV vs GSK
EFAV vs GSK Comparison Chart in %
Loading...
loading
loading
View a ticker or compare two or three
VS
VS
EFAV vs. GSK commentary
Aug 30, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EFAV is a StrongBuy and GSK is a Hold.
SUMMARIES
FUNDAMENTALS RATINGS
GSK: Fundamental Ratings
GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 10 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 19 Undervalued | |
PROFIT vs RISK RATING 1..100 | 42 | |
SMR RATING 1..100 | 34 | |
PRICE GROWTH RATING 1..100 | 57 | |
P/E GROWTH RATING 1..100 | 57 | |
SEASONALITY SCORE 1..100 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TECHNICAL ANALYSIS
Technical Analysis
| EFAV | GSK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 74% | N/A |
| Stochastic ODDS (%) | 2 days ago 74% | 2 days ago 47% |
| Momentum ODDS (%) | 2 days ago 82% | 2 days ago 70% |
| MACD ODDS (%) | 2 days ago 73% | 2 days ago 43% |
| TrendWeek ODDS (%) | 2 days ago 74% | 2 days ago 52% |
| TrendMonth ODDS (%) | 2 days ago 74% | 2 days ago 50% |
| Advances ODDS (%) | 16 days ago 77% | 12 days ago 63% |
| Declines ODDS (%) | 2 days ago 74% | 3 days ago 53% |
| BollingerBands ODDS (%) | 2 days ago 60% | 3 days ago 45% |
| Aroon ODDS (%) | 2 days ago 78% | 2 days ago 39% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
EFAV and
Correlation & Price change
A.I.dvisor indicates that over the last year, EFAV has been loosely correlated with RIO. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if EFAV jumps, then RIO could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To EFAV | 1D Price Change % | ||
|---|---|---|---|---|
| EFAV | 100% | -0.22% | ||
| RIO - EFAV | 50% Loosely correlated | -1.41% | ||
| SAN - EFAV | 49% Loosely correlated | +0.82% | ||
| RTO - EFAV | 44% Loosely correlated | +0.26% | ||
| GSK - EFAV | 42% Loosely correlated | +1.09% | ||
| RACE - EFAV | 39% Loosely correlated | +1.57% | ||
More | ||||
GSK and
Correlation & Price change
A.I.dvisor indicates that over the last year, GSK has been loosely correlated with NVS. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if GSK jumps, then NVS could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y